October 2, 2024
The HSCIP is a formal partnership agreement between the Association of the British Pharmaceutical Industry (ABPI) and MOIC (MOIC act on behalf of Health and Social Care NI) where parties work together to introduce transformative, medicines-related innovations across the Health and Social Care system. The partnership enables identification of areas of mutual interest to improve the diagnosis, treatment and care of patients.
The HSCIP shared goal is to deliver ‘triple win’ benefits to patients, the Service and the economy through more rapid and consistent patient access to innovation, more effective use of HSC resources and increased cross-sector research collaboration.
HSCIP aims include:
- Rapid and consistent patient access to innovation
- More effective use of HSC resources
- Increased cross sector research collaboration
- Step change in the pace and consistency of adoption of evidence based innovative medicines and technologies
Example Area: Cardiovascular Services
The Northern Ireland Regional HF Transformation Project
MOIC/ABPI worked with the Cardiac Clinical Network (led by Strategic Planning and Performance Group) and a commercial partner to review the patient pathway for heart failure services in NI. Mapping workshops of the current pathway were held with representatives from HSC Trusts alongside Task and Finish groups to model a ‘gold standard’ future service specification. The Northern Ireland Regional HF Transformation Project report detailed recommendations for a future state service specification based on gold standards of care and evidence-based guidelines to create a more streamlined and equitable future heart failure service in NI. An implementation phase of work with HSC Trusts is ongoing.